ABIVAX: cashflow_financing
| Value | {"amount": 335290000.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | ABIVAX |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T22:37:46.312492+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/2c5f901f-6d3b-4cdd-91d0-b2a4366cdc0e
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:969500D8TMNB184OJU95:2025-12-31Retrieved: 2026-08-23T22:37:46.312492+02:00
Raw response sha256:
2b28964747a505fce6b394187dfae1ff…Cite as: FACTANKER, https://factanker.com/fact/2c5f901f-6d3b-4cdd-91d0-b2a4366cdc0e
History
- no predecessors — first report